Chronic graft loss: dealing with the vascular alterations in solid organ transplantation.
Research Department, Novartis Pharma AG, Basel, Switzerland.
N S
NS
Cook
H G
HG
Zerwes
M
M
Rudin
N
N
Beckmann
H J
HJ
Schuurman
D000818:Animals; D001011:Aorta / Q000473:pathology / Q000637:transplantation; D002908:Chronic Disease; D006084:Graft Rejection / Q000209:etiology* / Q000276:immunology / Q000503:physiopathology; D006086:Graft vs Host Disease / Q000276:immunology / Q000473:pathology / Q000503:physiopathology; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology / Q000473:pathology; D009926:Organ Preservation; D016377:Organ Transplantation; D015427:Reperfusion Injury; D014184:Transplantation, Homologous / Q000276:immunology / Q000473:pathology